Global COPD Drugs Market Forecast to 2023 COPD Market Report | Page 15

List of Figures
Figure No. Figure Title Figure 61: U.S., Population ages 65 and above, 2013-2017 (% of total) 80
Figure 62: U.S., Population ages 65 and above, Forecast (In Millions) 80
Figure 63: U.S., Per Capita Expenditure on Healthcare, 2012-2018E (In USD) 80
Figure 64: U.S., GDP (Current USD), 2013-2017 (In USD Trillion) 80
Figure 65: USA COPD Drugs Market Size, By Drug Type, 2017 (%) 81
Figure 66: USA COPD Drugs Market Size, By Drug Type, 2023F (%) 81
Figure 67: USA COPD Drugs Market, By Drug Type, By Value, 2013-2017 (USD Million) 82
Figure 68: USA COPD Drugs Market, By Drug Type, By Value, 2018-2023(USD Million) 82
Figure 69: Canada COPD Drugs Market, By Value, 2013-2017 (USD Million) 84
Figure 70: Canada COPD Drugs Market, By Value, 2018-2023(USD Million) 84
Figure 71: Percentage Change in Deaths Between, 2007–2017 Due to Respiratory Diseases 85
Figure 72: Canada, PM2.5 air pollution, mean annual exposure (micrograms per cubic meter), 2012-2016 86
Figure 73: Canada, Smoking Prevalence, Age 15+, 2012-2016 86
Figure 74: Number of Retail Pharmacies in Canada, 2013-2017 87
Figure 75: Number of Hospitals Establishments in Canada, By Province, 2015 87
Figure 76: Canada, Expenditure on Health as a share of GDP, 2012-2017 (in %) 88
Figure 77: Canada, Per Capita Healthcare Expenditure, 2012-2017 (USD) 88
Figure 78: Canada, Population ages 65 and above, 2012-2017 (% of total) 88
Figure 79: Canada COPD Drugs Market Size, By Drug Type, 2017 (%) 89
Figure 80: Canada COPD Drugs 89
Market Size, By Drug Type, 2023F (%)
(c) AZOTH Analytics
Page No.